4//SEC Filing
Gros David-Alexandre C 4
Accession 0000899243-20-025169
CIK 0001404281other
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 8:12 PM ET
Size
6.1 KB
Accession
0000899243-20-025169
Insider Transaction Report
Form 4
Gros David-Alexandre C
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-09-11+18,278.14→ 18,278.14 totalExercise: $500.00Exp: 2020-09-11→ Series X1 Convertible Preferred Stock (18,278.14 underlying)
Footnotes (2)
- [F1]This option represents a right to purchase a total of 18,278.14 shares of the Issuer's Series X1 Convertible Preferred Stock, one quarter of which will become fully vested and exercisable on September 11, 2021, with the remaining 13,708.605 shares vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date.
- [F2]Each share of Series X1 Convertible Preferred Stock will be convertible into 1,000 shares of Common Stock upon receipt of the requisite approval of the stockholders of the Issuer.
Documents
Issuer
Novus Therapeutics, Inc.
CIK 0001404281
Entity typeother
Related Parties
1- filerCIK 0001644489
Filing Metadata
- Form type
- 4
- Filed
- Sep 14, 8:00 PM ET
- Accepted
- Sep 15, 8:12 PM ET
- Size
- 6.1 KB